-
2023-507633-21-00
5
Neurological Disease
-
2025-520678-20-00
5
Adult patients with symptomatic and inflammatory Hand osteoarthritis H
-
2023-505500-37-00
5
Pregnant women with singleton pregnancies hospitalized for threatened
-
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
-
2023-509421-41-03
5
Bacterial vaginosis
-
2024-513292-40-00
5
Multiple sclerosis
-
2024-513724-42-00
10
Medulloblastoma
-
2024-513889-19-00
5
Multiple Myeloma
-
2024-515462-14-00
6
Long term potential effect of repeated exposure to either a linear or
-
2024-516115-24-00
9
High risk relapsed neuroblastoma (relapsed or progressed after being d
-
2024-516215-24-00
4
TAkayasu ARteritiS
-
2024-519246-75-01
4
Patients With Muscle-Invasive Bladder Cancer
-
2024-519818-31-01
5
Endometrial Cancer
Advanced, Recurrent, Metastatic, or Primary Unresec
-
2024-520414-21-00
5
Adult patients with a LVOS with large core within 9 hours of symptoms
-
2025-520632-42-00
5
axial or predominantly axial SpA with or without psoriasis
-
2025-520842-31-00
5
Population of study participants Pregnant women with PPROM at 22 to 33
-
2025-521039-35-00
5
Impact on delirium of the use of DEXmedetomidine as first-line sedati
-
2025-521113-13-00
10
Early Parkinson’s Disease
-
2025-521331-36-00
10
Patient with stabilized SSc-ILD (as defined by a decline of FVC ≤ 5%)
-
2025-521371-31-00
4
Sepsis
-
2025-521632-12-00
5
Patients on Factor Xa inhibitor treatment needing an urgent interventi
-
2025-522138-29-00
4
Philadelphia positive Chronic Myeloid leukemia in Chronic Phase with n
-
2025-522193-37-00
5
Septic arthritis
-
2025-522748-42-00
5
Ovarian cancer